Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.
Curr Oncol
; 27(3): e332-e335, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-646931
ABSTRACT
The emergence of the covid-19 disease pandemic caused by the 2019 novel coronavirus has required a re-evaluation of treatment practices for clinicians caring for patients with chronic lymphocytic leukemia (cll). The American Society for Hematology (ash) has provided a series of recommendations for the treatment of patients with cll during the pandemic, covering a range of topics, including testing for covid-19, cll treatment initiation and selection, use of immunoglobulin therapy, in-person monitoring, and treatment of patients with cll and covid-19. We summarize the ash recommendations and discuss their applicability as guidelines for the treatment of cll during the covid-19 pandemic in Canada.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Leukemia, Lymphocytic, Chronic, B-Cell
/
Coronavirus Infections
/
Immunologic Factors
/
Antineoplastic Agents
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Curr Oncol
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS